Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression

od de Wit, Meike, Carvalho, Beatriz, Delis-van Diemen, Pien M., van Alphen, Carolien, Beliën, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Izdano u PLoS One (2017)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

od Greijer, Astrid E., Delis-van Diemen, Pien M., Fijneman, Remond J. A., Giles, Rachel H., Voest, Emile E., van Hinsbergh, Victor W. M., Meijer, Gerrit A.
Izdano 2008

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

od Sillars-Hardebol, Anke H., Carvalho, Beatriz, de Wit, Meike, Postma, Cindy, Delis-van Diemen, Pien M., Mongera, Sandra, Ylstra, Bauke, van de Wiel, Mark A., Meijer, Gerrit A., Fijneman, Remond J. A.
Izdano 2010

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer progno...

od Nugteren, Sandrine, Goos, Jeroen A.C.M., Delis-van Diemen, Pien M., Simons-Oosterhuis, Ytje, Lindenbergh-Kortleve, Dicky J., van Haaften, Daniëlle H., Sanders, Joyce, Meijer, Gerrit A., Fijneman, Remond J.A., Samsom, Janneke N.
Izdano u Oncoimmunology (2020)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer

od de Wit, Meike, Belt, Eric J. Th., Delis-van Diemen, Pien M., Carvalho, Beatriz, Coupé, Veerle M. H., Stockmann, Hein B. A. C., Bril, Herman, Beliën, Jeroen A. M., Fijneman, Remond J. A., Meijer, Gerrit A.
Izdano 2012

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

od van den Broek, Evert, den Uil, Sjoerd H., Coupé, Veerle M.H., Delis-van Diemen, Pien M., Bolijn, Anne S., Bril, Herman, Stockmann, Hein B.A.C., van Grieken, Nicole C.T., Meijer, Gerrit A., Fijneman, Remond J.A.
Izdano u Oncotarget (2018)

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify

od Komor, Malgorzata A., Pham, Thang V., Hiemstra, Annemieke C., Piersma, Sander R., Bolijn, Anne S., Schelfhorst, Tim, Delis-van Diemen, Pien M., Tijssen, Marianne, Sebra, Robert P., Ashby, Meredith, Meijer, Gerrit A., Jimenez, Connie R., Fijneman, Remond J. A.
Izdano u Mol Cell Proteomics (2017)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients

od Vleugels, Jasper L.A., van Neerven, Sanne M., van Leerdam, Monique E., Wanders, Linda K., de Wit, Meike, Carvalho, Beatriz, Delis-van Diemen, Pien M., Kallenberg, Frank G.J., Vermeulen, Louis, Beliën, Jeroen A., East, James E., Meijer, Gerrit A., Dekker, Evelien
Izdano u Endosc Int Open (2019)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

od den Uil, Sjoerd H., van den Broek, Evert, Coupé, Veerle M. H., Vellinga, Thomas T., Delis-van Diemen, Pien M., Bril, Herman, Belt, Eric J. Th., Kranenburg, Onno, Stockmann, Hein B. A. C., Belien, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Izdano u BMC Gastroenterol (2019)

Consensus molecular subtype classification of colorectal adenomas

od Komor, Malgorzata A, Bosch, Linda JW, Bounova, Gergana, Bolijn, Anne S, Delis‐van Diemen, Pien M, Rausch, Christian, Hoogstrate, Youri, Stubbs, Andrew P, de Jong, Mark, Jenster, Guido, van Grieken, Nicole CT, Carvalho, Beatriz, Wessels, Lodewyk FA, Jimenez, Connie R, Fijneman, Remond JA, Meijer, Gerrit A
Izdano u J Pathol (2018)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9

od Goos, Jeroen A.C.M., Coupé, Veerle M.H., van de Wiel, Mark A., Diosdado, Begoña, Delis-Van Diemen, Pien M., Hiemstra, Annemieke C., de Cuba, Erienne M.V., Beliën, Jeroen A.M., Menke - van der Houven van Oordt, C. Willemien, Geldof, Albert A., Meijer, Gerrit A., Hoekstra, Otto S., Fijneman, Remond J.A.
Izdano u Oncotarget (2015)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

od Lenos, Kristiaan, Goos, Jeroen A.C.M., Vuist, Ilona M., den Uil, Sjoerd H., Delis-van Diemen, Pien M., Belt, Eric J.Th., Stockmann, Hein B.A.C., Bril, Herman, de Wit, Meike, Carvalho, Beatriz, Giblett, Susan, Pritchard, Catrin A., Meijer, Gerrit A., van Kooyk, Yvette, Fijneman, Remond J.A., van Vliet, Sandra J.
Izdano u Oncotarget (2015)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

od den Uil, Sjoerd H, Coupé, Veerle M H, Linnekamp, Janneke F, van den Broek, Evert, Goos, Jeroen A C M, Delis-van Diemen, Pien M, Belt, Eric J Th, van Grieken, Nicole C T, Scott, Patricia M, Vermeulen, Louis, Medema, Jan Paul, Bril, Herman, Stockmann, Hein B A C, Cormier, Robert T, Meijer, Gerrit A, Fijneman, Remond J A
Izdano u Br J Cancer (2016)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

od Komor, Malgorzata A., de Wit, Meike, van den Berg, Jose, Martens de Kemp, Sanne R., Delis‐van Diemen, Pien M., Bolijn, Anne S., Tijssen, Marianne, Schelfhorst, Tim, Piersma, Sander R., Chiasserini, Davide, Sanders, Joyce, Rausch, Christian, Hoogstrate, Youri, Stubbs, Andrew P., de Jong, Mark, Jenster, Guido, Carvalho, Beatriz, Meijer, Gerrit A., Jimenez, Connie R., Fijneman, Remond J.A.
Izdano u Int J Cancer (2019)